Affinity labeling of the proteasome by a belactosin A derived inhibitor

Bioorganic & Medicinal Chemistry Letters
2008.0

Abstract

Belactosin A is a potent proteasome inhibitor isolated from Streptomyces metabolites. Here we show that a hydrophobic belactosin A derivative, dansyl-KF33955, can covalently, and specifically, affinity label the catalytic subunits of the 26S proteasome, which consists of the 20S protein degrading core particle and the 19S regulatory particles. The labeling of catalytic subunits proceeds faster in intact proteasomes in vivo than in isolated 20S core particles. These data suggest that the 19S regulatory particle may facilitate entry of the inhibitor into the 20S core particle. This cell-permeable chemical probe is an excellent tool with which to study the interactions of this proteasome inhibitor with proteasomes in intact cells.

Knowledge Graph

Similar Paper

Affinity labeling of the proteasome by a belactosin A derived inhibitor
Bioorganic & Medicinal Chemistry Letters 2008.0
A new structural class of proteasome inhibitors identified by microbial screening using yeast-based assay
Biochemical Pharmacology 2004.0
Potent Proteasome Inhibitors Derived from the Unnatural cis-Cyclopropane Isomer of Belactosin A: Synthesis, Biological Activity, and Mode of Action
Journal of Medicinal Chemistry 2013.0
Synthesis and biological evaluation of boron peptide analogues of Belactosin C as proteasome inhibitors
Bioorganic & Medicinal Chemistry Letters 2009.0
Structurally Novel Highly Potent Proteasome Inhibitors Created by the Structure-Based Hybridization of Nonpeptidic Belactosin Derivatives and Peptide Boronates
Journal of Medicinal Chemistry 2014.0
Optimization of Subsite Binding to the β5 Subunit of the Human 20S Proteasome Using Vinyl Sulfones and 2-Keto-1,3,4-oxadiazoles:  Syntheses and Cellular Properties of Potent, Selective Proteasome Inhibitors
Journal of Medicinal Chemistry 2006.0
New betulinic acid derivatives as potent proteasome inhibitors
Bioorganic & Medicinal Chemistry Letters 2011.0
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors
ACS Medicinal Chemistry Letters 2019.0
A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybrids
Bioorganic & Medicinal Chemistry 2017.0
α,β-Unsaturated N-Acylpyrrole Peptidyl Derivatives: New Proteasome Inhibitors
Journal of Medicinal Chemistry 2010.0